Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Observational Study on the Taulí-T1 Classification for Staging, Prognosis, and Management of pT1 Rectal Adenocarcinoma (TAUTEM-pT1 Study)

NCT06218108 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.

NCT NCT06218108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06218108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Observational Study on the Taulí-T1 Classification for Staging, Prognosis, and Management of pT1 Rectal Adenocarcinoma (TAUTEM-pT1 Study)
Lead sponsor
Corporacion Parc Tauli
Phase
Observational
Overall status
Unknown status
Start date
October 2, 2023
Completion date
January 5, 2026
Enrollment
317 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer stage i